Genomic medicine is rapidly advancing and pretty much mainstream into healthcare. The dataset of a single human genome is vast ocean of information that sets him or her apart from everyone out there.  As a result response to any medical treatment is going to be very unique that will reflect the genetic make up of the person. 

The last few years has steadily seen genomics becoming more mainstream in the medical discipline. It has become more regular to see the the use of personal genomic data as a part of regular clinical care (e.g. for diagnostic and therapeutic decision making). They are also rapidly becoming instrumental in policy implications determining the outcomes of serious clinical diagnoses like cancer into mainstream medicine. 

Today, the overall major biochemical pathways are fairly well established. So also are the cell-signalling pathways in the human body. Though a lot remains to be gleaned the major ones are out there. The genes for them are sequenced and mutations in each of them well documented and observed at clinical level. All of these have also been fairly well culled into the countless databases most of which are even publicly accessible. 

All being said, the implications of every new 'variant' and its clinical significance is still vastly under-addressed. The question still remains if any 'alteration' in the genetic sequence at a particular location has any clinical relevance and more so with respect to the treatment outcomes for the given individual.  Thus clinical reporting of variants itself is in the process of standardization.

Queromatics hopes to address the area of genomic medicine - one dataset at a time; one web based solution at a time.  

Do call us/contact us to know more about how we can team up to and collaborate to make such research solutions possible and the ones we have already developed.  

EIN: 83-2805054

Guidestar link: Queromatics

DONATE through Network for Good